Αποτελέσματα Αναζήτησης
The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and ensuring future competitiveness in an advancing global economy. In 2023 it invested an estimated € 50,000 million in R&D in Europe.
The global pharmaceutical market size was estimated at USD 1,482.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.12% from 2023 to 2030.
Welcome to Ten years on, the tenth annual report from the Deloitte Centre for Health Solutions exploring the performance of the biopharmaceutical industry (biopharma) and its ability to generate returns from investment in innovative new products.
INTRODUCTION. at 1,135 billion U.S. dollars.1 The market has. decade and is predicted to continue this trend. For the European Union, a growth rate of 3.1 percent2 until 2022 is estimated, for North America 5.4 percent3. . The pharmaceutical industry is part of the global health economy, which in 2014 was.
The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and ensuring future competitiveness in an advancing global economy. In 2020 it invested an estimated € 39,000 million in R&D in Europe.
The global pharmaceutical manufacturing market size was estimated at USD 516.48 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.63% from 2023 to 2030. The pharmaceutical industry has experienced a significant shift due to advancements in technology, cost-effective manufacturing methods, and increased investment.
The research-based pharmaceutical industry can play a critical role in restoring economic growth in Europe and ensuring future competitiveness in an advancing global economy. In 2022 it invested an estimated €44,500 million in R&D in Europe.
